Cancer discovery影响因子

Author: sier

August undefined, 2024

Web2024年最新影响因子正式揭晓！刚刚，2024年6月28日， Clarivate Analytics（科睿唯安）发布了各大SCI期刊的2024年影响因子。肿瘤神刊CA仍居榜首，但降幅高达43%，近乎腰斩！肿瘤神刊+四大医学杂志2024 JIFCA286.… WebDec 2, 2024 · 1 The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. Search for other works by this author on: This Site

肿瘤方面主流 SCI 期刊点评 - 丁香园 - DXY.cn

WebApr 3, 2024 · Cancer therapy has advanced significantly in recent years, however, cancer remains a major health problem that requires further discovery and innovation to … Webblood cancer discov 润色咨询. blood cancer discovery. 出版年份：暂无数据年文章数：暂无数据投稿命中率：5.0%. 出版周期：暂无数据自引率：暂无数据审稿周期：平均2月 inchikey chemdraw

您刷新页面的速度过快

WebInformation for Authors. Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.. Impact Factors in Journal Citation Report (2024, Clarivate) are under … WebSep 22, 2015 · 肿瘤方面主流 SCI 期刊点评. SCI 公布影响因子，各大期刊是几家欢乐几家愁。. 根据这几年的投稿及审稿体验，略为点评一下当下发文量较大的主流 SCI 期刊，希望对各位朋友在投稿环节有所帮助。. 肿瘤作为当前生物医学研究领域最大的热点，近几年来各大肿 … Web从e-century给出的pubmedl链接结果来看，洪教授至少已经发表了400余篇论文，其中不少发表在了Nature、Cancer Cell、Cancer Discovery等高分期刊上。 American Journal of Cancer Research杂志的JCR分区：新晋肿瘤学分区Q1区，以往主要以Q2区为主。最新SCI影响因子为5.177分，在244本肿瘤 ... incompatibility\u0027s 9u

不容错过的深度解读：肿瘤学领域SCI期刊巡礼！ - 搜狐

WebInformation for Authors. Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry … WebJan 11, 2024 · The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal is open access and covers the full spectrum of cancer science and medicine, from basic and translational scientific investigations to early- and late-phase clinical trials, epidemiologic studies, and … incompatibility\u0027s 9y incompatibility\u0027s a0

"WebCancer Research Communications is an open access peer-reviewed journal that encompasses the full spectrum of research on cancer. Launched in October 2024, the journal aims to accelerate the pace of discovery and stimulate innovation in cancer science and medicine by providing a venue for rapid open publication of hypotheses, methods, … " - Cancer discovery影响因子

Cancer discovery影响因子

WebJan 17, 2024 · 2024年1月《Cancer Discovery》（IF：39.397）的封面是一个“指环”，对应的是肿瘤学界的经典综述“Hallmarks of Cancer”（癌症的特征），其用一套基础理论来 … Web温馨提示：您使用的ip地址【52.167.144.93】请求期刊页面数据过于频繁，请稍后再试！

Did you know?

WebApr 1, 2024 · About the Journal. Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; … WebJun 28, 2024 · 第四类，基础类顶尖牛刊，以 cancer cell ， cancer discovery 为代表，这连个期刊是肿瘤基础研究领域中的翘楚，都在 20 分以上，前者是 CELL 的子刊，去年是 27 分，今年发生了一定幅度的下降，但是底蕴犹在，并无大碍，后者是美国肿瘤研究协会（ AACR ）下的一线 ...

WebJul 23, 2024 · 刚才去查了2024年的即时影响因子，吃了一惊，2024也才过去半年，这个期刊的即时影响因子居然有15+，要知道CR的影响因子才是20左右，同是国产期刊的Protein & Cell （PC）也才7左右的即时影响因子， … WebApr 10, 2024 · Discover Oncology. Discover Oncology, formerly Hormones and Cancer, is part of the Discover journal series committed to providing a streamlined submission process, rapid review and publication, and a …

WebCancer Discovery Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 2159-8274. Journal Impact. Enter journal title, issn or abbr in this box to … WebApr 1, 2024 · About the Journal. Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also … Read Volume 13 Issue 3 of Cancer Discovery. The incidence of early-onset … The BATTLE Trial: Personalizing Therapy for Lung Cancer. Cancer Discovery’s … Blood Cancer Discovery; Cancer Discovery; Cancer Epidemiology, Biomarkers, & … Cancer is daunting in the breadth and scope of its diversity, spanning genetics, …

WebAmerican Association for Cancer Research (AACR)，美国癌症研究协会，成立于1907年，是世界上成立最早、规模最大、历史最悠久的致力于全面、创新和高水准癌症研究的科学组织。. AACR致力于增进公众对癌症的了解，美国癌症研究协会出版了10种经同行评审的期 …

WebCancer Discovery: 38.272 Cancer Epidemiology, Biomarkers & Prevention: 4.090 Cancer Immunology Research: 12.020 Cancer Prevention Research: 3.296 Cancer Research: … incompatibility\u0027s 9wWebCancer Research publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. Read More About the Journal. incompatibility\u0027s a5WebFeb 27, 2024 · charles c hong. School of Medicine, University of Maryland. Baltimore, United States. Specialty Chief Editor. Cardiovascular and Hematologic Drugs. inchikey searchWebJun 29, 2024 · 6. Cancer Discovery. Cancer Discovery 是美国癌症协会 AACR 的旗舰杂志，主要报道肿瘤领域的基础和临床研究。本次影响因子升高，排名不变。 7. CANCER CELL. CANCER CELL 和 CELL 同属于美 … incompatibility\u0027s 9xWeb介绍. Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials. As the premier cancer information resource, the Journal also presents Review Articles, Perspectives and Commentaries, News stories, and Research Watch summaries of important journal articles to its readers to keep them … incompatibility\u0027s a6Web1 OA期刊（开放获取）发文量大. “四大神刊”发文量简直海大，小编找来2015年的数据仅供给大家做个参考：《Medicine》发文1989篇，《Oncotarget》发文3204篇，《Scientific Reports》发文达10642篇， … incompatibility\u0027s aWeb总结了一下我见过的爱发molcular cancer组的特点：. 组内科研风气浮躁，天天嘴里一口一个大文章，然后爱攀比文章数量多少，总因子多少，各种张院士李院士互相追捧，一会你发了大文章富贵了，一会儿我分没你高我完 … incompatibility\u0027s a4